SOL Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
SOL Capital Management's GILD Position: Q1 2021 in Review
SOL Capital Management sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 4,990 shares — an estimated $291K sold.
SOL Capital Management first reported a position in GILD in Q3 2016 and held it in 18 quarters. The position peaked at $976K in Q3 2018. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.
- SOL Capital Management reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
- SOL Capital Management sold 4,990 Gilead Sciences shares in Q1 2021, an estimated $291K.
- SOL Capital Management first reported a position in Gilead Sciences in Q3 2016 and held it in 18 quarters.
- SOL Capital Management's Gilead Sciences position peaked at $976K in Q3 2018.
- 1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.
Based on SOL Capital Management's 13F filing for Q1 2021, filed 22 Apr 2021.